Rigel Pharmaceuticals Inc (RIGL) is lower by 5.13% Monday In Premarket Trading

Rigel Pharmaceuticals Inc (RIGL) has fallen Monday morning, with the stock decreasing -5.13% in pre-market trading to 1.11. RIGL's short-term technical score of 41 indicates that the stock has traded less bullishly over the last month than 59% of stocks on the market. In the Biotechnology industry, which ranks 130 out of 146 industries, RIGL ranks higher than 62% of stocks. Rigel Pharmaceuticals Inc has fallen 12.03% over the past month, closing at $1.38 on July 31. During this period of time, the stock fell as low as $1.10 and as high as $1.40. RIGL has an average analyst recommendation of Buy. The company has an average price target of $4.18.

RIGL has an Overall Score of 56. Find out what this means to you and get the rest of the rankings on RIGL!

See Full RIGL Report

Rigel Pharmaceuticals Inc has a Long-Term Technical rank of 31. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 69% of the market scoring higher. In the Biotechnology industry which is number 127 by this metric, RIGL ranks better than 127% of stocks.

Important Dates for Investors in RIGL:

-Rigel Pharmaceuticals Inc is set to release earnings on 2023-10-30. Over the last 12 months, the company has reported EPS of $-0.22. -We do not have a set dividend date for Rigel Pharmaceuticals Inc at this time. Click Here To Get The Full Report on Rigel Pharmaceuticals Inc (RIGL)